AbbVie Inc
abbvie.comAbbVie Inc (NYSE: ABBV) is a biopharmaceutical company that researches, develops, manufactures, and sells medicines and therapies across therapeutic areas on a global basis. Revenue is generated through the commercialization and sale of prescription pharmaceutical products, with commercial efforts organized by geographic region or therapeutic area. AbbVie operates as a single global business segment, as disclosed in its 10-K filed 2026-02-20, with a unified research and development and supply chain organization responsible for discovery, development, manufacturing, and product supply worldwide. The company is incorporated in Delaware and headquartered in Texas, and its common stock trades on the New York Stock Exchange.
Products & Services
Innovative medicines and therapies across multiple therapeutic areas. Specific product names and brand details are referenced in the 10-K filed 2026-02-20 under Item 7 and Item 1, but are not reproduced in sufficient detail in the available excerpts to enumerate here.
Revenue Model
Transactional sales of prescription medicines and therapies to patients and healthcare systems, organized commercially by geographic region or therapeutic area. AbbVie operates as a single reporting segment with no disclosed segment revenue breakdown in the available filing excerpts.
Customers & Markets
End markets are organized by geographic region and therapeutic area per the 10-K filed 2026-02-20. Specific customer types such as hospitals, pharmacies, or payers are not detailed in the available filing excerpts.
Geographic Exposure
Global operations with commercial efforts organized by geographic region. Specific country or regional revenue breakdowns are referenced in Note 16 of the 10-K filed 2026-02-20 but are not reproduced in the available excerpts.
Financial Snapshot
Loading...
